Repro Med Systems Stock Investor Sentiment
| KRMD Stock | USD 3.52 0.06 1.68% |
About 55% of Repro Med's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Repro Med Systems stock suggests that some investors are interested at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
Repro |
Repro Med Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.
Repro Med Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Linda Tharby of 19681 shares of Repro Med at 2.09 subject to Rule 16b-3 | 09/20/2024 |
2 | Acquisition by Manko Joseph M. Jr. of 5454 shares of Repro Med subject to Rule 16b-3 | 09/30/2024 |
3 | Acquisition by Cascella Robert of 5454 shares of Repro Med at 2.75 subject to Rule 16b-3 | 10/01/2024 |
4 | Further weakness as KORU Medical Systems drops 10 percent this week, taking five-year losses to 38 | 10/09/2024 |
5 | LivaNova Tops Q3 Earnings and Revenue Estimates | 10/30/2024 |
6 | KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusio... | 10/31/2024 |
7 | Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3 | 11/08/2024 |
8 | KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth Raises Full Year 2024 Guidance | 11/13/2024 |
9 | Koru Medical Systems stock target increased, holds buy on strong quarter | 11/14/2024 |
10 | KORU Medical Systems, Inc. Q3 2024 Earnings Call Transcript | 11/15/2024 |
11 | KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com Australia | 11/21/2024 |
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance |